BBS-Bioactive Bone Substitutes Oyj (HE:BONEH) — Market Cap & Net Worth
Market Cap & Net Worth: BBS-Bioactive Bone Substitutes Oyj (BONEH)
BBS-Bioactive Bone Substitutes Oyj (HE:BONEH) has a market capitalization of $1.50 Million (€1.29 Million) as of August 28, 2026. Listed on the HE stock exchange, this Finland-based company holds position #30334 globally and #150 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BBS-Bioactive Bone Substitutes Oyj's stock price €0.05 by its total outstanding shares 27942900 (27.94 Million). Check today's stock price for BBS-Bioactive Bone Substitutes Oyj for real-time trading data and today's change.
BBS-Bioactive Bone Substitutes Oyj Market Cap History: 2018 to 2026
BBS-Bioactive Bone Substitutes Oyj's market capitalization history from 2018 to 2026. Data shows change from $67.95 Million to $1.76 Million (-42.00% CAGR).
Index Memberships
BBS-Bioactive Bone Substitutes Oyj is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Finland EUR PI
FNFIEURPI
|
$1.71 Billion | 0.09% | #21 of 25 |
Weight: BBS-Bioactive Bone Substitutes Oyj's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
BBS-Bioactive Bone Substitutes Oyj Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BBS-Bioactive Bone Substitutes Oyj's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check BBS-Bioactive Bone Substitutes Oyj (BONEH) shareholders funds to evaluate the company's book value and shareholders' equity.
Latest Price to Sales (P/S) Ratio
559.07x
BBS-Bioactive Bone Substitutes Oyj's market cap is 559.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $59.09 Million | $105.69K | -$1.64 Million | 559.07x | N/A |
Competitor Companies of BONEH by Market Capitalization
Companies near BBS-Bioactive Bone Substitutes Oyj in the global market cap rankings as of August 28, 2026. Also see BONEH cash generation efficiency for how efficiently the company converts equity into cash flow.
Key companies related to BBS-Bioactive Bone Substitutes Oyj by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #198 globally with a market cap of $126.45 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #232 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #248 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $114.10 |
| #198 | Stryker Corporation | NYSE:SYK | $126.45 Billion | $329.67 |
| #232 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.02 |
| #248 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
BBS-Bioactive Bone Substitutes Oyj Historical Marketcap From 2018 to 2026
Between 2018 and today, BBS-Bioactive Bone Substitutes Oyj's market cap moved from $67.95 Million to $ 1.76 Million, with a yearly change of -42.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.76 Million | 0.00% |
| 2025 | €1.76 Million | +1.51% |
| 2024 | €1.73 Million | -89.16% |
| 2023 | €15.97 Million | -59.08% |
| 2022 | €39.04 Million | -45.43% |
| 2021 | €71.54 Million | -53.99% |
| 2020 | €155.50 Million | +163.17% |
| 2019 | €59.09 Million | -13.04% |
| 2018 | €67.95 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 27th, 2026 the market cap of BBS-Bioactive Bone Substitutes Oyj was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.50 Million USD |
| MoneyControl | $1.50 Million USD |
| MarketWatch | $1.50 Million USD |
| marketcap.company | $1.50 Million USD |
| Reuters | $1.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot… Read more